This inventor holds 3 USPTO granted patents, plus 3 CIPO patents and 4 EPO patents. Top assignees: Marinomed Biotech Ag, Nicox S.a.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Vienna, AT (2019 - 2020)
- Steyregg-Plesching, AT (2022)
Company Filing History:
Years Active: 2019-2022
Title: Angelika Bodenteich: Innovator in Pharmaceutical Solutions
Introduction
Angelika Bodenteich is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of pharmaceuticals, particularly in developing methods to enhance drug solubility and create effective antiviral compositions. With a total of 3 patents to her name, her work has the potential to impact various therapeutic applications.
Latest Patents
One of her latest patents is a method for improving the aqueous solubility of water-insoluble or slightly water-soluble drugs. This innovative approach involves adding a saponin component, such as escin or glycyrrhizin, to an aqueous solvent. The process includes pre-dissolving the hydrophobic organic compound in an organic solvent before mixing it with the aqueous solvent, resulting in an increased concentration of the organic compound in the solution. This method is particularly useful for pharmaceutical or cosmetic compositions that require higher solubility of active ingredients.
Another notable patent is a stuffy nose deblocking composition that exhibits antiviral activity. This pharmaceutical composition utilizes a hyperosmolar aqueous solution combined with non-ionic and ionic osmolality adjusting agents. It includes iota-carrageenan and/or kappa-carrageenan as active ingredients, which are effective in treating nasal congestion and preventing viral infections of the upper respiratory tract.
Career Highlights
Throughout her career, Angelika Bodenteich has worked with several notable companies, including Marinomed Biotech AG and Nicox S.A. Her expertise in pharmaceutical sciences has allowed her to develop innovative solutions that address critical health issues.
Collaborations
Angelika has collaborated with esteemed colleagues such as Andreas Grassauer and Eva Prieschl-Grassauer. These partnerships have contributed to her success in the field and have fostered a collaborative environment for innovation.
Conclusion
Angelika Bodenteich's contributions to pharmaceutical innovations demonstrate her commitment to improving health outcomes through her inventive solutions. Her patents reflect a deep understanding of drug formulation and antiviral therapies, positioning her as a key figure in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile